MedTrace Logo

An Evaluation of the Memory at Work Program

NCT01236664 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2011-10-12

No results posted yet for this study

Summary

With the aging of the Canadian population, older workers are accounting for more and more of the working-age population. Despite recent interest in cognitive training, there are currently no validated programs that specifically target individuals in the work force. The investigators will conduct a small-scale randomized controlled trial to test the effectiveness of the previously developed Memory at Work program. The investigators will recruit 60 individuals and randomly assign them to the active intervention or a control intervention. The investigators will examine outcomes related to knowledge, behavioral change, self-efficacy, objective memory, and workplace productivity. The investigators expect larger improvements on these measures in the active relative to the control group.

Conditions

  • Cognition - Other
  • Ageing

Interventions

BEHAVIORAL

Memory training

The Memory at Work program is a 4-hour classroom-based workshop that is led by a professional trainer. The format of the program is experiential, with a heavy focus on discussion, self-discovery, and hands-on use of trained skills. Specific memory compensation techniques are trained. Training consists of an explanation of each technique (i.e., how and when to use it, the science behind the technique) and ample opportunities for hands-on use of the strategies.

BEHAVIORAL

Control Workshop

The control workshop consists of a 4-hour program that will train techniques for successfully completing Sudoku, word, and logic puzzles. Like the experimental intervention, the control workshop will be engaging and challenging, and will involve a combination of individual and group activities.

Sponsors & Collaborators

  • Cogniciti Inc.

    collaborator INDUSTRY

  • Baycrest

    lead OTHER

Principal Investigators

  • Angela K. Troyer, PhD · Baycrest

  • Kelly J Murphy, PhD · Baycrest

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01236664 on ClinicalTrials.gov